These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 1664242)

  • 41. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature.
    Peters M; Timm U; Schürmann D; Pohle HD; Ruf B
    Clin Investig; 1992 May; 70(5):456-8. PubMed ID: 1318131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Foscarnet for cytomegalovirus retinitis.
    Singer DR; Fallon TJ; Schulenburg WE; Williams G; Cohen J
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):962. PubMed ID: 2998255
    [No Abstract]   [Full Text] [Related]  

  • 43. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient.
    Knox KK; Drobyski WR; Carrigan DR
    Lancet; 1991 May; 337(8752):1292-3. PubMed ID: 1674092
    [No Abstract]   [Full Text] [Related]  

  • 44. Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
    Jacobson MA; Mills J; Rush J; O'Donnell JJ; Miller RG; Greco C; Gonzales MF
    Arch Neurol; 1988 Oct; 45(10):1090-2. PubMed ID: 2845899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of genital erosions during treatments with foscarnet of cytomegalovirus infections in AIDS].
    Lowenstein W; Fadlallah JP; Roudière L; Deneux C; Haas C; Durand H
    Presse Med; 1991 Nov; 20(39):1951. PubMed ID: 1662375
    [No Abstract]   [Full Text] [Related]  

  • 46. Foscarnet sodium.
    Minor JR; Baltz JK
    DICP; 1991 Jan; 25(1):41-7. PubMed ID: 1848959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
    Control Clin Trials; 1992 Feb; 13(1):22-39. PubMed ID: 1315661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
    Polis MA
    Am J Med; 1992 Feb; 92(2A):22S-25S. PubMed ID: 1310572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Foscarnet infusion at home.
    Wood G; Whitby M; Hogan P; Frazer I
    Lancet; 1989 Jan; 1(8630):156. PubMed ID: 2563066
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cytomegalovirus ileocolitis in patients with HIV infection is a treatable cause of severe abdominal problems].
    Söderlund C; Bratt G; Grützmeier S; Rieger A; Sandström E; Sjunnesson M
    Lakartidningen; 1991 Dec; 88(49):4249-50. PubMed ID: 1721990
    [No Abstract]   [Full Text] [Related]  

  • 51. Extrapulmonary cytomegalovirus disease in transplant patients.
    Petersen EA
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):13-6. PubMed ID: 1647557
    [No Abstract]   [Full Text] [Related]  

  • 52. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.
    Farthing C; Anderson MG; Ellis ME; Gazzard BG; Chanas AC
    J Med Virol; 1987 Jun; 22(2):157-62. PubMed ID: 3039052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fixed drug eruption due to foscarnet.
    Connolly GM; Gazzard BG; Hawkins DA
    Genitourin Med; 1990 Apr; 66(2):97-8. PubMed ID: 2160425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Heinemann MH
    Am J Med; 1992 Feb; 92(2A):12S-16S. PubMed ID: 1310570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
    Chrisp P; Clissold SP
    Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
    Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA
    Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    Walmsley SL; Chew E; Read SE; Vellend H; Salit I; Rachlis A; Fanning MM
    J Infect Dis; 1988 Mar; 157(3):569-72. PubMed ID: 2830347
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary.
    Balfour HH; Drew WL; Hardy WD; Heinemann MH; Polsky B
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S37-44. PubMed ID: 1318367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytomegalovirus infection in patients after lung transplantation].
    Cerrina J; Le Roy Ladurie F
    Presse Med; 1992 Mar; 21(11):503-6. PubMed ID: 1315436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.